Jazz Pharmaceuticals

Jazz Pharmaceuticals is a global biopharmaceutical company specializing in oncology and neuroscience, with a portfolio that includes key products such as Xyrem for narcolepsy and Vyxeos for acute myeloid leukemia. The company operates through a combination of internal development and strategic acquisitions, maintaining a strong market position in rare disease and specialty therapeutics. Jazz is publicly traded and recognized for its innovative approach and expanding global footprint.

Company Facts

• Headquarters: Dublin, Ireland
• Founded: 2003
• Employees: 3,000
• Type: Public Corporation
• Website: https://www.jazzpharma.com
• Industries: Pharmaceuticals, Biotechnology, Oncology, Neuroscience, Rare Diseases